http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2163773-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_977ebb660999f345084ffad260515ff6 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-06 |
| filingDate | 1995-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e120ca889f4310a881bb785f82cab79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfe0cac7a43fff3100d5b10f1b7aa0f5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ca1a97f2cb293096f371ec365ef8e5b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d581177fecd431e86ec3ae65b1ca30e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ba16c64b4a5f9e5e676c9358705a440 |
| publicationDate | 1995-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2163773-A1 |
| titleOfInvention | Abeo-ergoline derivatives as 5ht1a ligands |
| abstract | There are provided compounds of formula (I), wherein R1 is a hydrogen, chlorine or bromine atom or a methyl, methylthio, hydroxy, cyano or carboxamido group; R2 is C1-C3 alkyl or an allyl group; R3 and R4 are independently a hydrogen atom, a C1-C5 alkyl group, a C3-C5 alkenyl group, a C5-C6 cycloalkyl C1-C3 alkyl group, a phenyl-C1-C3 alkyl, a phenyl -C3-C5 alkenyl or phenyl group: which groups are optionally substituted by C1-C3 alkyl, C1-C3 alkoxy, trifluoromethyl, hydroxy or amino group; or a group of formula (a), wherein R6 is hydrogen atom or a C1-C3 alkyl group and R7 is a phenyl group, a substituted phenyl group as described above or a heterocyclic ring, R5 is a hydrogen or bromine atom or an organic residue and R is H or an organic residue, or a pharmaceutically acceptable salt thereof. A process for their preparation and the pharmaceutical compositions comprising them are also provided. |
| priorityDate | 1994-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 146.